Alliance A061202. A phase I/II study of pomalidomide, dexamethasone and ixazomib versus pomalidomide and dexamethasone for patients with multiple myeloma refractory to lenalidomide and proteasome inhibitor based therapy: Phase I results.
- Citation:
- Blood vol 126 (23) abstr 375
- Meeting Instance:
- ASH 2015
- Year:
- 2015
- Type:
- Abstract
- Sub type:
- Oral
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Preliminary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 3494
- Pharmas:
- Grants:
- U10CA180821, U10CA180882, UG1CA189823
- Corr. Author:
- Authors:
- Peter M. Voorhees Flora Mulkey Hani Hassoun Claudia E. Paba-Prada Yvonne Efebera Eva Hoke Guadalupe Aquino Destin Carlisle Vera Suman Paul G. Richardson
- Networks:
- LAPS-MA036, LAPS-NY016, NC002, OH008
- Study
- Alliance-A061202
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 1/2
- Keywords: